This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

High Yield Dividend Stocks Setting New Yearly Highs

JNJ Dividend Yield Chart JNJ Dividend Yield data by YCharts

Johnson & Johnson (JNJ - Get Report)

Background: The world's sixth-largest consumer health company. The world's largest and most diverse medical devices and diagnostics company. The world's fifth-largest biologics company and the world's eighth-largest pharmaceuticals company.

52-Week Range: $61.71 to $72.74

Book Value: $20.95

Price To Book: 3.3

Earnings Payout Percentage: 77%

Investors are receiving $2.44 in dividends for a yield of 3.5%. On Aug. 29, I wrote about J&J and the closing price was $67.37. It didn't take long for J&J to move higher, and along with the capital gain, J&J paid 61 cents in dividends since. Conversely, the S&P 500 (SPY) didn't fare quite as well. The overall market is down slightly.

Analysts as a whole like this company. Currently, Johnson & Johnson has 14 buy recommendations out of 26 analysts covering the company, along with 11 holds, and one rates it as a sell.

Shares have really appreciated, gaining 12% in the last year, and the average analyst target price is $75.13.





With short interest above 5%, investors will want to monitor changes to know if short sellers turn up the warning signals. Otherwise, the current 5.8% of the float short is relatively small and not a major concern. It's actually declined since my Aug. 29 article, a very good sign.

JNJ Payout Ratio TTM Chart JNJ Payout Ratio TTM data by YCharts
-----------------------------------------------------

4 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
CAG $38.44 0.00%
CSCO $28.95 0.00%
JNJ $100.82 0.00%
MO $51.28 0.00%
PG $79.14 0.00%

Markets

DOW 18,041.54 -190.48 -1.04%
S&P 500 2,104.20 -21.86 -1.03%
NASDAQ 5,032.7510 -56.6110 -1.11%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs